09:48 AM EDT, 10/08/2024 (MT Newswires) -- WW International ( WW ) said Tuesday it has added compounded semaglutide to its offering, enhancing access to clinical weight management products for eligible members.

This new option aims to provide an affordable alternative amid ongoing shortages of GLP-1 medications like Ozempic and Wegovy, which have seen limited availability at pharmacies, WW International ( WW )' Interim Chief Executive Officer Tara Comonte said.

WW International ( WW ) shares were up 8% in early trading.

Price: 0.85, Change: +0.06, Percent Change: +8.02